Cargando…

Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia: Clinical Facts and Fiction

The antileukemic mechanisms of 6-mercaptopurine (6MP) and methotrexate (MTX) maintenance therapy are poorly understood, but the benefits of several years of myelosuppressive maintenance therapy for acute lymphoblastic leukemia are well proven. Currently, there is no international consensus on drug d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmiegelow, Kjeld, Nielsen, Stine N., Frandsen, Thomas L., Nersting, Jacob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222610/ https://www.ncbi.nlm.nih.gov/pubmed/24936744 http://dx.doi.org/10.1097/MPH.0000000000000206

Ejemplares similares

Challenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemia
por: Nersting, Jacob, et al.
Publicado: (2011)

Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia
por: Larsen, Rikke Hebo, et al.
Publicado: (2021)

Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia
por: Mogensen, Pernille Rudebeck, et al.
Publicado: (2020)

Pharmacokinetic–pharmacodynamic modeling of maintenance therapy for childhood acute lymphoblastic leukemia
por: Gebhard, Anna, et al.
Publicado: (2023)

DNA polymerase gamma variants and hepatotoxicity during maintenance therapy of childhood acute lymphoblastic leukemia: is there a causal relationship?
por: Harju, Tekla, et al.
Publicado: (2023)

Relating genomic variation to drug response in childhood acute lymphoblastic leukemia by multiplexed targeted sequencing
por: Wesolowska, Agata, et al.
Publicado: (2010)

Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
por: Wojtuszkiewicz, Anna, et al.
Publicado: (2015)

Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation
por: Choi, Yong Won, et al.
Publicado: (2015)

Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy
por: Schmiegelow, Kjeld, et al.
Publicado: (2017)

Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations
por: Toksvang, Linea N., et al.
Publicado: (2022)

Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions
por: Thastrup, Maria, et al.
Publicado: (2022)

Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia
por: Alsous, Mervat, et al.
Publicado: (2017)

Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia
por: Zhang, Melissa, et al.
Publicado: (2019)

Epidemiology of Therapy-Related Myeloid Neoplasms After Treatment for Pediatric Acute Lymphoblastic Leukemia in the Nordic Countries.
por: Schmiegelow, Kjeld
Publicado: (2011)

Flow Cytometric Detection of Malignant Blasts in Cerebrospinal Fluid: A Biomarker of Central Nervous System Involvement in Childhood Acute Lymphoblastic Leukemia
por: Thastrup, Maria, et al.
Publicado: (2022)

Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization.
por: Lilleyman, J. S., et al.
Publicado: (1984)

Prognostic significance of hepatotoxicity during maintenance chemotherapy for childhood acute lymphoblastic leukaemia.
por: Schmiegelow, K., et al.
Publicado: (1990)

Maternal diabetes and risk of childhood acute lymphoblastic leukaemia in the offspring
por: Søegaard, Signe Holst, et al.
Publicado: (2018)

Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?
por: Adashek, Jacob J., et al.
Publicado: (2020)

MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy
por: Umerez, Maitane, et al.
Publicado: (2017)

High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia
por: Jastaniah, Wasil, et al.
Publicado: (2018)

Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia
por: Conneely, Shannon E., et al.
Publicado: (2020)

Screening of Novel Pharmacogenetic Candidates for Mercaptopurine-Induced Toxicity in Patients With Acute Lymphoblastic Leukemia
por: Cao, Minyuan, et al.
Publicado: (2020)

Can Machine Learning Models Predict Asparaginase-associated Pancreatitis in Childhood Acute Lymphoblastic Leukemia
por: Nielsen, Rikke L., et al.
Publicado: (2022)

Incidence and determinants of hematotoxicity in acute lymphoblastic leukemia children who received 6-mercaptopurine based maintenance therapy in Addis Ababa, Ethiopia
por: Ali, Awol Mekonnen, et al.
Publicado: (2023)

Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review
por: Toksvang, Linea Natalie, et al.
Publicado: (2019)

"Osmiophilia," Fact or Fiction?
por: Ornstein, Leonard
Publicado: (1957)

Asbestos: facts and fiction.
por: Mossman, B T
Publicado: (1994)

Transgenderism: Facts and fictions
por: O, Somasundaram
Publicado: (2009)

Science fact or fiction?
Publicado: (2008)

Science fact or fiction?
Publicado: (2008)

Leprosy: Facts and Fiction
Publicado: (1950)

Fact and Fiction in Psychology
por: Williams, Moyra
Publicado: (1965)

Munchausen: Fact and Fiction
por: Sakula, Alex
Publicado: (1978)

Fact, Fiction, and Fitness
por: Prakash, Chetan, et al.
Publicado: (2020)

Impact fact(or) fiction?
por: Spires-Jones, Tara L, et al.
Publicado: (2022)

Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study
por: Lynggaard, Line Stensig, et al.
Publicado: (2022)

Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity
por: Abedi, Marjan, et al.
Publicado: (2020)

APEX1 Polymorphism and Mercaptopurine-Related Early Onset Neutropenia in Pediatric Acute Lymphoblastic Leukemia
por: Kim, Hyery, et al.
Publicado: (2018)

MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia
por: Evensen, Nikki A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o17l2cp4cnvkkggufpcp2dm5k2